BridgeBio Pharma, Inc. (BBIO): SCHEDULE 13G/A filed Aug 3, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 3, 2026

Accession number

0000908834-26-000369

Filer

BridgeBio Pharma, Inc. (CIK 1743881)